Janus Henderson Group PLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Janus Henderson Group PLC

$182 Billion
Q2 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$144.95 - $152.29 $76.2 Million - $80.1 Million	-525,802 Reduced 48.89%	549,664 $83.1 Million
Q2 2022 Aug 15, 2022	SELL	$83.14 - $145.99 $136 Million - $238 Million	-1,630,686 Reduced 60.26%	1,075,466 $157 Million
Q1 2022 May 16, 2022	BUY	$110.08 - $142.92 $143 Million - $186 Million	1,299,597 Added 92.4%	2,706,152 $321 Million
Q4 2021 Feb 14, 2022	BUY	$99.73 - $148.48 $63.9 Million - $95.2 Million	641,180 Added 83.77%	1,406,555 $194 Million
Q3 2021 Nov 16, 2021	BUY	$98.85 - $138.91 $2.72 Million - $3.82 Million	27,480 Added 3.72%	765,375 $106 Million
Q2 2021 Aug 16, 2021	BUY	$65.78 - $105.02 $1.31 Million - $2.09 Million	19,855 Added 2.77%	737,895 $71.6 Million
Q1 2021 May 17, 2021	BUY	$64.07 - $91.75 $46 Million - $65.9 Million	718,040 New	718,040 $49.1 Million
Q2 2019 Jul 31, 2019	SELL	$39.79 - $67.01 $49.8 Million - $83.9 Million	-1,251,607 Closed	0 $0
Q1 2019 Apr 30, 2019	SELL	$34.52 - $53.29 $65.3 Million - $101 Million	-1,892,151 Reduced 60.19%	1,251,607 $64.4 Million
Q4 2018 Feb 06, 2019	SELL	$29.75 - $42.9 $5.75 Million - $8.29 Million	-193,158 Reduced 5.79%	3,143,758 $116 Million
Q3 2018 Nov 09, 2018	BUY	$32.79 - $43.0 $1.23 Million - $1.62 Million	37,616 Added 1.14%	3,336,916 $125 Million
Q2 2018 Aug 10, 2018	SELL	$23.62 - $42.29 $2.29 Million - $4.09 Million	-96,830 Reduced 2.85%	3,299,300 $130 Million
Q1 2018 May 14, 2018	BUY	$22.49 - $34.56 $54.3 Million - $83.5 Million	2,416,021 Added 246.51%	3,396,130 $87.5 Million
Q4 2017 Feb 09, 2018	BUY	$20.44 - $35.56 $5.95 Million - $10.4 Million	291,200 Added 42.27%	980,109 $26.4 Million
Q3 2017 Nov 14, 2017	BUY	$23.54 - $38.21 $1.02 Million - $1.65 Million	43,166 Added 6.68%	688,909 $0
Q2 2017 Aug 17, 2017	BUY	N/A	645,743	645,743 $16.1 Million

Others Institutions Holding BHVN

# of Institutions

Shares Held

785K

Call Options Held

Put Options Held

View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

More about BHVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Account